Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Diabetes

  Free Subscription


Articles published in Am J Ophthalmol

Retrieve available abstracts of 96 articles:
HTML format



Single Articles


    July 2021
  1. STARR MR, Salabati M, Mahmoudzadeh R, Patel LG, et al
    Fluctuations in central subfield thickness associated with worse visual outcomes in patients with diabetic macular edema in clinical trial setting.
    Am J Ophthalmol. 2021 Jul 17. pii: S0002-9394(21)00359.
    PubMed     Abstract available


  2. MATSUNAGA DR, Salabati M, Obeid A, Wibbelsman TD, et al
    Outcomes of Eyes with Diabetic Macular Edema that are Lost to Follow-up after Anti-Vascular Endothelial Growth Factor Therapy.
    Am J Ophthalmol. 2021 Jul 17. pii: S0002-9394(21)00357.
    PubMed     Abstract available


    June 2021
  3. SOBRIN L, Susarla G, Stanwyck L, Rouhana JM, et al
    Gene Set Enrichment Analyses Identify Pathways Involved in Genetic Risk for Diabetic Retinopathy.
    Am J Ophthalmol. 2021 Jun 21. pii: S0002-9394(21)00336.
    PubMed     Abstract available


    April 2021
  4. ITO H, Ito Y, Kataoka K, Ueno S, et al
    Erratum to Association Between Retinal Layer Thickness and Perfusion Status in Extramacular Areas in Diabetic Retinopathy. Am J Ophthalmol 2020; 215:25-36.
    Am J Ophthalmol. 2021 Apr 13. pii: S0002-9394(20)30675.
    PubMed    


  5. STARR MR, Mahr MA, Smith WM, Iezzi R, et al
    Outcomes of patients with active diabetic macular edema at the time of cataract surgery managed with intravitreal anti-VEGF injections: Outcomes of cataract surgery in active DME patients.
    Am J Ophthalmol. 2021 Apr 11. pii: S0002-9394(21)00190.
    PubMed     Abstract available


  6. KHURANA RN, Hoang C, Khanani AM, Steklov N, et al
    A Smart Mobile Application to Monitor Visual Function in Diabetic Retinopathy and Age-related Macular Degeneration: The CLEAR Study: Mobile Device for Measuring Visual Acuity and Function.
    Am J Ophthalmol. 2021 Apr 5. pii: S0002-9394(21)00157.
    PubMed     Abstract available


    March 2021
  7. HUTTON DW, Glassman AR, Stein JD, Bressler NM, et al
    Costs of Managing Diabetic Macular Edema with Good Visual Acuity with Aflibercept, Laser or Observation: DRCR Retina Network Protocol V.
    Am J Ophthalmol. 2021 Mar 10. pii: S0002-9394(21)00103.
    PubMed     Abstract available


    February 2021
  8. ABRAHAM JR, Wykoff CC, Arepalli S, Lunasco L, et al
    Aqueous Cytokine Expression and Higher Order OCT Biomarkers: Assessment of the Anatomic-Biologic Bridge in the IMAGINE DME Study.
    Am J Ophthalmol. 2021;222:328-339.
    PubMed     Abstract available


    January 2021
  9. YU HJ, Ehlers JP, Sevgi DD, Hach J, et al
    Real-Time Photographic and Fluorescein Angiographic-Guided Management of Diabetic Retinopathy: Randomized PRIME Trial Outcomes.
    Am J Ophthalmol. 2021 Jan 30. pii: S0002-9394(21)00045.
    PubMed     Abstract available


  10. CHIANG JF, Sun MH, Chen KJ, Wu WC, et al
    Association Between Obstructive Sleep Apnea and Diabetic Macular Edema in Patients with Type 2 Diabetes.
    Am J Ophthalmol. 2021 Jan 30. pii: S0002-9394(21)00043.
    PubMed     Abstract available


  11. YU CW, Park LJ, Pinto A, Ma ON, et al
    The Impact of Bariatric Surgery on Diabetic Retinopathy: A Systematic Review and Meta-Analysis.
    Am J Ophthalmol. 2021 Jan 8. pii: S0002-9394(21)00007.
    PubMed     Abstract available


  12. CHANCELLOR J, Soliman MK, Shoults CC, Faramawi MF, et al
    Intraoperative complications and visual outcomes of cataract surgery in diabetes mellitus: a multicenter database study.
    Am J Ophthalmol. 2021 Jan 7. pii: S0002-9394(21)00001.
    PubMed     Abstract available


    December 2020
  13. AL-KHERSAN H, Russell JF, Lazzarini TA, Scott NL, et al
    Comparison Between Graders in Detection of Diabetic Neovascularization with Swept Source OCT Angiography and Fluorescein Angiography.
    Am J Ophthalmol. 2020 Dec 10. pii: S0002-9394(20)30654.
    PubMed     Abstract available


    November 2020
  14. EHLERS JP, Uchida A, Sevgi DD, Hu M, et al
    Retinal Fluid Volatility Associated with Interval Tolerance and Visual Outcomes in Diabetic Macular Edema in the VISTA Phase III Trial.
    Am J Ophthalmol. 2020 Nov 27. pii: S0002-9394(20)30639.
    PubMed     Abstract available


    October 2020
  15. OHLHAUSEN M, Payne C, Greenlee T, Chen AX, et al
    Impact and Characterization Of Delayed Panretinal Photocoagulation In Proliferative Diabetic Retinopathy.
    Am J Ophthalmol. 2020 Oct 20. pii: S0002-9394(20)30560.
    PubMed     Abstract available


  16. OSATHANUGRAH P, Sanjiv N, Siegel NH, Ness S, et al
    The Impact of Race on Short Term Treatment Response to Bevacizumab in Diabetic Macular Edema.
    Am J Ophthalmol. 2020 Oct 9. pii: S0002-9394(20)30551.
    PubMed     Abstract available


    September 2020
  17. ZHANG B, Chou Y, Zhao X, Yang J, et al
    Early detection of microvascular impairments with optical coherence tomography angiography in diabetic patients without clinical retinopathy: a meta-analysis.
    Am J Ophthalmol. 2020 Sep 22. pii: S0002-9394(20)30530.
    PubMed     Abstract available


  18. CHEN S, Moult EM, Zangwill L, Weinreb RN, et al
    Geometric Perfusion Deficits: A Novel OCT Angiography Biomarker for Diabetic Retinopathy Based on Oxygen Diffusion.
    Am J Ophthalmol. 2020 Sep 9. pii: S0002-9394(20)30500.
    PubMed     Abstract available


    July 2020
  19. YALAMANCHILI SP, Maatouk CM, Enwere DU, Conti TF, et al
    The Short-Term Effect of a Single Lapse in Anti-Vascular Endothelial Growth Factor Treatment for Diabetic Macular EdemaWithin Routine Clinical Practice.
    Am J Ophthalmol. 2020 Jul 5. pii: S0002-9394(20)30336.
    PubMed     Abstract available


    June 2020
  20. ENDO H, Kase S, Saito M, Yokoi M, et al
    Choroidal thickness in diabetic patients without diabetic retinopathy: a meta-analysis.
    Am J Ophthalmol. 2020 Jun 20. pii: S0002-9394(20)30277.
    PubMed    


  21. GREIG EC, Brigell M, Cao F, Levine ES, et al
    Macular and Peripapillary OCTA Metrics Predict Progression in Diabetic Retinopathy: A Sub-analysis of TIME-2b Study Data.
    Am J Ophthalmol. 2020 Jun 20. pii: S0002-9394(20)30295.
    PubMed     Abstract available


  22. TAKKAR B, Takkar A
    Reply to Comment on: Retinal and Corneal Neurodegeneration and Its Association to Systemic Signs of Peripheral Neuropathy in Type 2 Diabetes.
    Am J Ophthalmol. 2020 Jun 11. pii: S0002-9394(20)30176.
    PubMed    


  23. YANNUZZI NA, Smiddy WE, Flynn HW Jr
    Follow-up Non-Compliance: A Significant Risk Factor for Reduced Visual Outcomes in Patients With Diabetic Retinopathy.
    Am J Ophthalmol. 2020 Jun 11. pii: S0002-9394(20)30171.
    PubMed    


  24. HAFNER J, Zadrazil M, Grisold A, Ricken G, et al
    Comment on Retinal and Corneal Neurodegeneration and Its Association to Systemic Signs of Peripheral Neuropathy in Type 2 Diabetes.
    Am J Ophthalmol. 2020 Jun 11. pii: S0002-9394(20)30177.
    PubMed    


    May 2020
  25. SADDA SR, Nittala Mphil MG, Taweebanjongsin W, Verma A, et al
    Quantitative assessment of the severity of diabetic retinopathy.
    Am J Ophthalmol. 2020 May 21. pii: S0002-9394(20)30251.
    PubMed     Abstract available


  26. MULLER PL, Maloca P, Webster A, Egan C, et al
    Structural Features Associated with the Development and Progression of RORA Secondary to Maternally Inherited Diabetes and Deafness.
    Am J Ophthalmol. 2020 May 21. pii: S0002-9394(20)30253.
    PubMed     Abstract available


  27. MULLER PL, Tufail A
    Progression of Retinopathy Secondary to Maternally Inherited Diabetes and Deafness - Evaluation of Predicting Parameters.
    Am J Ophthalmol. 2020 May 8. pii: S0002-9394(20)30103.
    PubMed    


    April 2020
  28. YOU QS, Wang J, Guo Y, Pi S, et al
    Optical coherence tomography angiography avascular area association with one-year treatment requirement and disease progression in diabetic retinopathy.
    Am J Ophthalmol. 2020 Apr 29. pii: S0002-9394(20)30192.
    PubMed     Abstract available


  29. FINSTERER J, Scorza FA, Scorza CA
    Comment on Progression of Retinopathy Secondary to Maternally Inherited Diabetes and Deafness: Evaluation of Predicting Parameters.
    Am J Ophthalmol. 2020 Apr 28. pii: S0002-9394(20)30100.
    PubMed    


  30. KUANG TM, Xirasagar S, Kao YW, Shia BC, et al
    Association of Systemic Hypertension with Primary Open-Angle Glaucoma: A Population-Based Case-control Study.
    Am J Ophthalmol. 2020 Apr 28. pii: S0002-9394(20)30188.
    PubMed     Abstract available


  31. WASZCZYKOWSKA A, Zmyslowska A, Braun M, Zielonka E, et al
    Corneal abnormalities are novel clinical feature in Wolfram syndrome.
    Am J Ophthalmol. 2020 Apr 23. pii: S0002-9394(20)30180.
    PubMed     Abstract available


  32. GOVETTO A, Sarraf D, Hubschman JP, Tadayoni R, et al
    Distinctive Mechanisms and Patterns of Exudative Versus Tractional Intraretinal Cystoid Spaces as Seen With Multimodal Imaging.
    Am J Ophthalmol. 2020;212:43-56.
    PubMed     Abstract available


    March 2020
  33. GREEN M, Tien T, Ness S
    Predictors of Loss to Follow Up in Patients Being Treated for Proliferative Diabetic Retinopathy.
    Am J Ophthalmol. 2020 Mar 31. pii: S0002-9394(20)30123.
    PubMed     Abstract available


  34. ITO H, Ito Y, Kataoka K, Ueno S, et al
    Association between retinal layer thickness and perfusion status in extramacular areas in diabetic retinopathy.
    Am J Ophthalmol. 2020 Mar 26. pii: S0002-9394(20)30119.
    PubMed     Abstract available


  35. SURESH R, Yu H, Thoveson A, Swisher J, et al
    Loss to Follow-Up Among Patients with Proliferative Diabetic Retinopathy in Clinical Practice.
    Am J Ophthalmol. 2020 Mar 21. pii: S0002-9394(20)30111.
    PubMed     Abstract available


  36. CICINELLI MV, Rabiolo A, Zollet P, Capone L, et al
    Persistent or Recurrent Diabetic Macular Edema after Fluocinolone Acetonide 0.19 mg Implant: risk factors and management.
    Am J Ophthalmol. 2020 Mar 21. pii: S0002-9394(20)30116.
    PubMed     Abstract available


  37. ZHU Y, Cui Y, Wang JC, Lu Y, et al
    Different Scan Protocols Affect the Detection Rates of Diabetic Retinopathy Lesions by Wide-field Swept-Source Optical Coherence Tomography Angiography.
    Am J Ophthalmol. 2020 Mar 20. pii: S0002-9394(20)30102.
    PubMed     Abstract available


    February 2020
  38. QIN YJ, Chan SO, Lin HL, Zhang YQ, et al
    Increased expression of growth hormone-releasing hormone in fibrinous inflammation of proliferative diabetic retinopathy.
    Am J Ophthalmol. 2020 Feb 13. pii: S0002-9394(20)30059.
    PubMed     Abstract available


  39. HAINSWORTH DP, Gangula A, Ghoshdastidar S, Kannan R, et al
    Diabetic Retinopathy Screening Using a Gold Nanoparticle-Based Paper Strip Assay for the At-Home Detection of the Urinary Biomarker 8-Hydroxy-2'-deoxyguanosine (8-OHdG).
    Am J Ophthalmol. 2020 Feb 6. pii: S0002-9394(20)30050.
    PubMed     Abstract available


    January 2020
  40. RUSSELL JF, Al-Khersan H, Shi Y, Scott NL, et al
    Retinal Non-Perfusion in Proliferative Diabetic Retinopathy Before and After Panretinal Photocoagulation Assessed by Wide Field OCT Angiography.
    Am J Ophthalmol. 2020 Jan 29. pii: S0002-9394(20)30033.
    PubMed     Abstract available


  41. MULLER PL, Treis T, Pfau M, Esposti SD, et al
    Progression of Retinopathy Secondary to Maternally Inherited Diabetes and Deafness - Evaluation of Predicting Parameters.
    Am J Ophthalmol. 2020 Jan 24. pii: S0002-9394(20)30019.
    PubMed     Abstract available


  42. SANDHU HS, Elmogy M, El-Adawy N, Eltanboly A, et al
    Automated diagnosis of diabetic retinopathy using clinical biomarkers, optical coherence tomography (OCT), and OCT angiography.
    Am J Ophthalmol. 2020 Jan 23. pii: S0002-9394(20)30023.
    PubMed     Abstract available


    November 2019
  43. SRINIVAS S, Verma A, Nittala MG, Alagorie AR, et al
    Effect of intravitreal ranibizumab on intraretinal hard exudates in eyes with diabetic macular edema.
    Am J Ophthalmol. 2019 Nov 20. pii: S0002-9394(19)30562.
    PubMed     Abstract available


    September 2019
  44. HAFNER J, Zadrazil M, Grisold A, Ricken G, et al
    Retinal and corneal neurodegeneration and its association to systemic signs of peripheral neuropathy in type 2 diabetes.
    Am J Ophthalmol. 2019 Sep 19. pii: S0002-9394(19)30468.
    PubMed     Abstract available


    August 2019
  45. FAN W, Nittala MG, Fleming A, Robertson G, et al
    Relationship Between Retinal Fractal Dimension and Non-perfusion in Diabetic Retinopathy on Ultra-Wide Field Fluorescein Angiography.
    Am J Ophthalmol. 2019 Aug 28. pii: S0002-9394(19)30416.
    PubMed     Abstract available


    June 2019
  46. YORGUN MA
    Effects of Crocin on Diabetic Maculopathy: A Placebo-Controlled Randomized Clinical Trial.
    Am J Ophthalmol. 2019 Jun 27. pii: S0002-9394(19)30129.
    PubMed    


  47. SEPAHI S, Mohajeri SA, Hosseini SM, Khodaverdi E, et al
    Effects of Crocin on Diabetic Maculopathy: A Placebo-Controlled Randomized Clinical Trial.
    Am J Ophthalmol. 2019 Jun 20. pii: S0002-9394(19)30128.
    PubMed    


  48. VAIL D, Callaway NF, Ludwig CA, Saroj N, et al
    Lipid-Lowering Medications are Associated with Lower Risk of Retinopathy and Ophthalmic Interventions among U.S. Patients with Diabetes.
    Am J Ophthalmol. 2019 Jun 10. pii: S0002-9394(19)30264.
    PubMed     Abstract available


  49. RUSSELL JF, Flynn HW Jr, Sridhar J, Townsend JH, et al
    Distribution of Diabetic Neovascularization on Ultra-Widefield Fluorescein Angiography and on Simulated Widefield OCT Angiography.
    Am J Ophthalmol. 2019 Jun 10. pii: S0002-9394(19)30266.
    PubMed     Abstract available


    May 2019
  50. LAVILLE V, Kang JH, Cousins CC, Iglesias AI, et al
    Genetic correlations between diabetes and glaucoma: an analysis of continuous and dichotomous phenotypes.
    Am J Ophthalmol. 2019 May 20. pii: S0002-9394(19)30245.
    PubMed     Abstract available


  51. MAN RE, Gan AT, Gupta P, Fenwick EK, et al
    Is Myopia associated with the Incidence and Progression of Diabetic Retinopathy?
    Am J Ophthalmol. 2019 May 16. pii: S0002-9394(19)30232.
    PubMed     Abstract available


  52. AREVALO JF, Lasave AF, Kozak I, Al Rashaed S, et al
    Preoperative Intravitreal Bevacizumab for Tractional Retinal Detachment Secondary to Proliferative Diabetic Retinopathy: Prospective Randomized Clinical Trial of the Pan-American Collaborative Retina Study (PACORES) Group.
    Am J Ophthalmol. 2019 May 13. pii: S0002-9394(19)30227.
    PubMed     Abstract available


  53. FAWZI AA, Fayed AE, Linsenmeier RA, Gao J, et al
    IMPROVED MACULAR CAPILLARY FLOW ON OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY AFTER PANRETINAL PHOTOCOAGULATION FOR PROLIFERATIVE DIABETIC RETINOPATHY.
    Am J Ophthalmol. 2019 May 9. pii: S0002-9394(19)30214.
    PubMed     Abstract available


  54. FAN W, Nittala MG, Velaga SB, Hirano T, et al
    Distribution of Non-perfusion and Neovascularization on Ultra-Wide Field Fluorescein Angiography in Proliferative Diabetic Retinopathy (RECOVERY Study): Report 1.
    Am J Ophthalmol. 2019 May 9. pii: S0002-9394(19)30204.
    PubMed     Abstract available


  55. SPAIDE RF
    Measurable Aspects Of The Retinal Neurovascular Unit In Diabetes, Glaucoma And Controls.
    Am J Ophthalmol. 2019 May 9. pii: S0002-9394(19)30217.
    PubMed     Abstract available


    April 2019
  56. INANC M, Tekin K, Kiziltoprak H, Ozalkak S, et al
    Changes in Retinal Microcirculation Precede the Clinical Onset of Diabetic Retinopathy in Children with Type 1 Diabetes Mellitus.
    Am J Ophthalmol. 2019 Apr 19. pii: S0002-9394(19)30186.
    PubMed     Abstract available


  57. FELFELI T, Juncal VR, Hillier RJ, Mak MY, et al
    Aqueous Humor Cytokines and Long-Term Response to Anti-Vascular Endothelial Growth Factor Therapy in Diabetic Macular Edema.
    Am J Ophthalmol. 2019 Apr 5. pii: S0002-9394(19)30151.
    PubMed     Abstract available


  58. FANG M, Fan W, Shi Y, Ip MS, et al
    Classification of Regions of Nonperfusion on Ultra-widefield Fluorescein Angiography in patients with Diabetic Macular Edema.
    Am J Ophthalmol. 2019 Apr 5. pii: S0002-9394(19)30141.
    PubMed     Abstract available


  59. GRZYBOWSKI A, Adamiec-Mroczek J
    Diabetes Alone Does Not Impair Recovery From Uneventful Cataract Surgery.
    Am J Ophthalmol. 2019;200:224-225.
    PubMed    


    March 2019
  60. WUBBEN TJ, Johnson MW
    Anti-VEGF Therapy for Diabetic Retinopathy: Consequences of Inadvertent Treatment Interruptions.
    Am J Ophthalmol. 2019 Mar 13. pii: S0002-9394(19)30103.
    PubMed     Abstract available


    February 2019
  61. TAIPALE C, Ilveskoski L, Danni R, Tuuminen R, et al
    Diabetes Alone Does Not Impair Recovery From Uneventful Cataract Surgery.
    Am J Ophthalmol. 2019 Feb 8. pii: S0002-9394(19)30017.
    PubMed    


  62. PAVKOV ME, Harding JL, Chou CF, Saaddine JB, et al
    Prevalence of Diabetic Retinopathy and Associated Mortality Among Diabetic Adults With and Without Chronic Kidney Disease.
    Am J Ophthalmol. 2019;198:200-208.
    PubMed     Abstract available


    January 2019
  63. ROSEN RB, Andrade Romo JS, Krawitz BD, Mo S, et al
    Earliest Evidence of Preclinical Diabetic Retinopathy Revealed using OCT Angiography (OCTA) Perfused Capillary Density.
    Am J Ophthalmol. 2019 Jan 25. pii: S0002-9394(19)30025.
    PubMed     Abstract available


    December 2018
  64. MAGGIO E, Sartore M, Attanasio M, Maraone G, et al
    Reply to: Anti-Vascular Endothelial Growth Factor Treatment for Diabetic Macular Edema in a Real-World Clinical Setting.
    Am J Ophthalmol. 2018 Dec 21. pii: S0002-9394(18)30597.
    PubMed    


  65. GANDHI JS
    Anti-Vascular Endothelial Growth Factor Treatment for Diabetic Macular Edema in a Real-World Clinical Setting.
    Am J Ophthalmol. 2018 Dec 20. pii: S0002-9394(18)30596.
    PubMed    


  66. LUTSKI M, Shohat T, Mery N, Zucker I, et al
    Incidence and risk factors for blindness in adults with diabetes: the Israeli National Diabetes Registry (INDR).
    Am J Ophthalmol. 2018 Dec 19. pii: S0002-9394(18)30679.
    PubMed     Abstract available


  67. HAGENAU F, Vogt D, Ziada J, Guenther SR, et al
    Vitrectomy for diabetic macular edema: optical coherence tomography criteria and pathology of the vitreomacular interface.
    Am J Ophthalmol. 2018 Dec 14. pii: S0002-9394(18)30673.
    PubMed     Abstract available


  68. LIU R, Ma B, Gao Y, Ma B, et al
    Tear Inflammatory Cytokines Analysis and Clinical Correlations in Diabetes and Non-diabetes with Dry Eye.
    Am J Ophthalmol. 2018 Dec 12. pii: S0002-9394(18)30669.
    PubMed     Abstract available


    October 2018
  69. DANNI R, Taipale C, Ilveskoski L, Tuuminen R, et al
    Diabetes alone does not impair recovery from uneventful cataract surgery.
    Am J Ophthalmol. 2018 Oct 8. pii: S0002-9394(18)30572.
    PubMed     Abstract available


  70. PARRAVANO M, De Geronimo D, Scarinci F, Virgili G, et al
    Progression of diabetic microaneurysms according to the internal reflectivity on structural OCT and visibility on OCT angiography.
    Am J Ophthalmol. 2018 Oct 8. pii: S0002-9394(18)30573.
    PubMed     Abstract available


  71. PAN J, Chen D, Yang X, Zou R, et al
    Characteristics of Neovascularization in Early Stages of Proliferative Diabetic Retinopathy by Optical Coherence Tomography Angiography.
    Am J Ophthalmol. 2018 Oct 6. pii: S0002-9394(18)30504.
    PubMed    


  72. CHOWDHARY N, Shrivastav A, Koundanya VV, Mayor R, et al
    Characteristics of Neovascularization in Early Stages of Proliferative Diabetic Retinopathy by Optical Coherence Tomography Angiography.
    Am J Ophthalmol. 2018 Oct 5. pii: S0002-9394(18)30503.
    PubMed    


    September 2018
  73. MAGGIO E, Sartore M, Attanasio M, Maraone G, et al
    Anti-VEGF Treatment for Diabetic Macular Edema in a Real-World Clinical Setting.
    Am J Ophthalmol. 2018 Sep 29. pii: S0002-9394(18)30490.
    PubMed    


  74. CALUGARU D, Calugaru M
    Anti-VEGF Treatment for Diabetic Macular Edema in a Real-World Clinical Setting.
    Am J Ophthalmol. 2018 Sep 27. pii: S0002-9394(18)30489.
    PubMed    


  75. KIM K, Kim ES, Yu SY
    Longitudinal relationship between retinal diabetic neurodegeneration and progression of diabetic retinopathy in patients with type 2 diabetes.
    Am J Ophthalmol. 2018 Sep 6. pii: S0002-9394(18)30515.
    PubMed     Abstract available


    August 2018
  76. PAN J, Chen D, Yang X, Zou R, et al
    Characteristics of Neovascularization in Early Stages of Proliferative Diabetic Retinopathy by Optical Coherence Tomography Angiography.
    Am J Ophthalmol. 2018 Aug 27. pii: S0002-9394(18)30411.
    PubMed    


  77. OLI A, Balakrishnan D
    Characteristics of Neovascularization in Early Stages of Proliferative Diabetic Retinopathy by Optical Coherence Tomography Angiography.
    Am J Ophthalmol. 2018 Aug 25. pii: S0002-9394(18)30410.
    PubMed    


  78. MORA N, Kempen JH, Sobrin L
    Diabetic Retinopathy in Hispanics: A Perspective on Disease Burden.
    Am J Ophthalmol. 2018 Aug 20. pii: S0002-9394(18)30473.
    PubMed     Abstract available


  79. MAGGIO E, Sartore M, Attanasio M, Maraone G, et al
    Anti-VEGF Treatment for Diabetic Macular Edema in a Real-World Clinical Setting.
    Am J Ophthalmol. 2018 Aug 8. pii: S0002-9394(18)30444.
    PubMed     Abstract available


  80. BRESSLER NM, Beaulieu WT, Maguire MG, Glassman AR, et al
    Early Response to Anti-Vascular Endothelial Growth Factor and Two-Year Outcomes Among Eyes with Diabetic Macular Edema in Protocol T.
    Am J Ophthalmol. 2018 Aug 2. pii: S0002-9394(18)30413.
    PubMed     Abstract available


    July 2018
  81. CHEN T, Zhu W, Tang B, Jin L, et al
    A Mobile Phone Informational Reminder to Improve Eyecare Adherence among Diabetic Patient in Rural China: A Randomized Controlled Trial.
    Am J Ophthalmol. 2018 Jul 24. pii: S0002-9394(18)30387.
    PubMed     Abstract available


    June 2018
  82. CALUGARU D, Calugaru M
    Vision Outcomes Following Anti-Vascular Endothelial Growth Factor Treatment of Diabetic Macular Edema in Clinical Practice.
    Am J Ophthalmol. 2018 Jun 30. pii: S0002-9394(18)30293.
    PubMed    


    May 2018
  83. PAN J, Chen D, Yang X, Zou R, et al
    Characteristics of Neovascularization in Early Stages of Proliferative Diabetic Retinopathy by Optical Coherence Tomography Angiography.
    Am J Ophthalmol. 2018 May 25. pii: S0002-9394(18)30236.
    PubMed     Abstract available


    April 2018
  84. HOLEKAMP NM, Campbell J, Almony A, Ingraham H, et al
    Vision Outcomes Following Anti-Vascular Endothelial Growth Factor Treatment of Diabetic Macular Edema in Clinical Practice.
    Am J Ophthalmol. 2018 Apr 20. pii: S0002-9394(18)30170.
    PubMed     Abstract available


  85. YU CG, Yuan SS, Yang LY, Ke J, et al
    Angiopoietin-like 3 is a Potential Biomarker for Retinopathy in Type 2 Diabetic Patients.
    Am J Ophthalmol. 2018 Apr 2. pii: S0002-9394(18)30155.
    PubMed     Abstract available


    March 2018
  86. SEPAHI S, Mohajeri SA, Hosseini SM, Khodaverdi E, et al
    Effects of crocin on diabetic maculopathy; a placebo controlled randomized clinical trial.
    Am J Ophthalmol. 2018 Mar 14. pii: S0002-9394(18)30105.
    PubMed     Abstract available


    February 2018
  87. HOU H, Shoji T, Zangwill LM, Moghimi S, et al
    Progression of Primary Open Angle Glaucoma in Diabetic and Non-diabetic Patients.
    Am J Ophthalmol. 2018 Feb 12. pii: S0002-9394(18)30051.
    PubMed     Abstract available


    January 2018
  88. CASTILLO J, Aleman I, Rush SW, Rush RB, et al
    Preoperative Bevacizumab Administration in Proliferative Diabetic Retinopathy Patients Undergoing Vitrectomy: A Randomized and Controlled Trial Comparing Interval Variation.
    Am J Ophthalmol. 2018 Jan 12. pii: S0002-9394(17)30537.
    PubMed    


  89. OLI A, Balakrishnan D, Rani PK
    Preoperative Bevacizumab Administration in Proliferative Diabetic Retinopathy Patients Undergoing Vitrectomy: A Randomized and Controlled Trial Comparing Interval Variation.
    Am J Ophthalmol. 2018 Jan 12. pii: S0002-9394(17)30538.
    PubMed    


  90. ZHANG XZ, Tu WJ, Wang H, Zhao Q, et al
    Circulating serum fatty acid binding protein 4 levels predict the development of the diabetic retinopathy in type 2 diabetic patients.
    Am J Ophthalmol. 2018 Jan 2. pii: S0002-9394(17)30560.
    PubMed     Abstract available


    December 2017
  91. GOWER EW, Lovato JF, Ambrosius WT, Chew EY, et al
    Lack of Longitudinal Association between Thiazolidinediones and Incidence and Progression of Diabetic Eye Disease: The ACCORD EYE Study.
    Am J Ophthalmol. 2017 Dec 21. pii: S0002-9394(17)30536.
    PubMed     Abstract available


  92. AL-KHERSAN H, Hariprasad SM, Chhablani J
    Early Response to Intravitreal Dexamethasone Implant Therapy in Diabetic Macular Edema May Predict Visual Outcome.
    Am J Ophthalmol. 2017 Dec 9. pii: S0002-9394(17)30470.
    PubMed    


  93. CALUGARU D, Calugaru M
    Early Response to Intravitreal Dexamethasone Implant Therapy in Diabetic Macular Edema May Predict Visual Outcome.
    Am J Ophthalmol. 2017 Dec 5. pii: S0002-9394(17)30474.
    PubMed    


    October 2017
  94. AL-KHERSAN H, Hariprasad SM, Chhablani J
    Early response to intravitreal dexamethasone implant therapy in diabetic macular edema may predict visual outcome.
    Am J Ophthalmol. 2017 Oct 12. pii: S0002-9394(17)30427.
    PubMed     Abstract available


  95. WANG JC, Lains I, Providencia J, Armstrong GW, et al
    Diabetic Choroidopathy: Choroidal Vascular Density and Volume in Diabetic Retinopathy with Swept-Source Optical Coherence Tomography.
    Am J Ophthalmol. 2017 Oct 5. pii: S0002-9394(17)30422.
    PubMed     Abstract available


  96. JOHNSON CA, Thapa S, George Kong YX, Robin AL, et al
    Performance of an iPad Application to Detect Moderate and Advanced Visual Field Loss in Nepal.
    Am J Ophthalmol. 2017;182:147-154.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diabetes is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: